Tag: Lunsumio
Roche: Lunsumio approved in lymphoma in the USA
(CercleFinance.com) – Genentech, the biotechnology subsidiary of Roche, announced on Friday that the US FDA has approved Lunsumio for the treatment of relapsed or refractory follicular lymphoma in adults. Lunsumio,…